Get startedLog in
    Picture of Daiichi Sankyo logo

    4568 — Daiichi Sankyo News Story

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapNeutral
    All News

    Merck, Daiichi Sankyo withdraw US application for lung cancer drug

    Picture of Daiichi Sankyo logoDaiichi Sankyo
    25/09/2026 21:37
    Merck, Daiichi Sankyo withdraw US application for lung cancer drug
    Sept 25 (Reuters) - Merck MRK.N and Daiichi Sankyo 4568.T have voluntarily withdrawn their US application seeking accelerated approval for their experimental lung cancer therapy, the drugmakers said on Friday.


     (Reporting by Kamal Choudhury in Bengaluru; Editing by Maju Samuel)
     ((Kamal.Choudhury@thomsonreuters.com;))

    Recent news on Daiichi Sankyo

    See all news